Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979563B details a recyclable ionic liquid method for high-purity pharmaceutical intermediates, offering significant cost reduction and simplified purification for global supply chains.
Novel acid-catalyzed route eliminates transition metals ensuring high purity pharmaceutical intermediates. Significant cost reduction and supply chain reliability for global procurement teams seeking scalable solutions.
Novel visible light catalysis method for indol-3-one derivatives. Offers mild conditions and high yield for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN106187815A reveals a novel Ni-Salen cage catalyst for high-selectivity sulfoxide synthesis. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN108164501A enables mild carbonyl sulfide conversion for high-purity intermediates. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Patent CN110156809A ionic liquid method offers high purity and cost reduction in fine chemical manufacturing for global supply chains ensuring reliable delivery.
Patent CN110963900A details a metal-free oxidative decarboxylation method using 4CzIPN and air, offering a green route for high-purity pharmaceutical intermediates manufacturing.
Patent CN103483306B reveals water-based polyamino ionic liquid catalysis for high-purity chromene derivatives, offering scalable cost reduction and supply reliability.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Novel heterogeneous catalyst method reduces Pd usage and enables recycling for sustainable furan derivative production.
Patent CN102351907A reveals a nickel-mediated transmetallation route for diverse metal-NHC catalysts, offering cost-effective manufacturing for pharmaceutical and fine chemical applications.
Patent CN110698369B reveals a mild visible-light method for synthesizing arylacetylene alkyl sulfones using alkyl fluoroborates, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Improved transaminase catalysis for sitagliptin reduces solvent use and enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN114315894B discloses a novel nickel-catalyzed synthesis of chiral alpha-aryl phosphates. This method offers mild conditions, high enantioselectivity, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN107417593A details efficient nano-cuprous chloride catalysis for fluorinated indoles, offering cost-effective scalable solutions for pharmaceutical supply chains.
Patent CN104402943A reveals a novel Pd-Cu heteronuclear catalyst for efficient quinoline derivative synthesis, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN110204491B details a novel Pd-catalyzed asymmetric C-H functionalization route for chiral 3,4-dihydroisoquinolinones, offering superior selectivity and cost efficiency for pharmaceutical manufacturing.